Literature DB >> 3375780

Contrast media as markers for glomerular filtration: a pharmacokinetic comparison of four agents.

S E Bäck1, E Krutzén, P Nilsson-Ehle.   

Abstract

In this study methods for the assay of the iodine-containing radiographic contrast agents metrizoate, amidotrizoate and iothalamate found in serum and urine have been developed. The method involved reverse-phase high-pressure liquid chromatography with spectrophotometric detection. This technique was used to compare the clearance of these agents, in a group of healthy female volunteers, after a single small-dose injection (5 ml, 2275-3235 mg). In the period 0-4 h after injection, serum elimination was approximated by a two-compartment model. However, a full description of drug fate in the body required at least three compartments. Plasma clearance was significantly different between agents with means of 191, 130, 144 and 121 ml/min for metrizoate, amidotrizoate, iothalamate and iohexol, respectively, whereas no difference was found between the renal/plasma clearance ratio. Protein binding measured with equilibrium dialysis did not suggest binding to serum proteins by any of these agents irrespective of concentration.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3375780     DOI: 10.3109/00365518809167491

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  15 in total

1.  Sleep and fatigue symptoms in children and adolescents with CKD: a cross-sectional analysis from the chronic kidney disease in children (CKiD) study.

Authors:  Maria-Eleni Roumelioti; Alicia Wentz; Michael F Schneider; Arlene C Gerson; Stephen Hooper; Mark Benfield; Bradley A Warady; Susan L Furth; Mark L Unruh
Journal:  Am J Kidney Dis       Date:  2010-01-19       Impact factor: 8.860

Review 2.  Glomerular filtration rate measurement and estimation in chronic kidney disease.

Authors:  George J Schwartz; Susan L Furth
Journal:  Pediatr Nephrol       Date:  2007-01-10       Impact factor: 3.714

3.  Iohexol-measured glomerular filtration rate in children and adolescents with chronic kidney disease: a pilot study comparing venous and finger stick methods.

Authors:  Amy Staples; Craig Wong; George J Schwartz
Journal:  Pediatr Nephrol       Date:  2018-10-12       Impact factor: 3.714

Review 4.  Measurement and Estimation of Glomerular Filtration Rate in Children.

Authors:  Ayesa N Mian; George J Schwartz
Journal:  Adv Chronic Kidney Dis       Date:  2017-11       Impact factor: 3.620

5.  Determination of glomerular filtration rate with Visipaque in patients with severely reduced renal function.

Authors:  P Kjaersgaard; J A Jakobsen; J O Nossen; K J Berg
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

Review 6.  An overview of the clinical pharmacokinetics of x-ray contrast media.

Authors:  M Bourin; P Jolliet; F Ballereau
Journal:  Clin Pharmacokinet       Date:  1997-03       Impact factor: 6.447

7.  Appraisal of GFR-estimating equations following kidney donation.

Authors:  Meghan Sebasky; Aleksandra Kukla; Erin Leister; Hongfei Guo; Sanjeev K Akkina; Yasser El-Shahawy; Arthur J Matas; Hassan N Ibrahim
Journal:  Am J Kidney Dis       Date:  2009-04-25       Impact factor: 8.860

8.  New equations to estimate GFR in children with CKD.

Authors:  George J Schwartz; Alvaro Muñoz; Michael F Schneider; Robert H Mak; Frederick Kaskel; Bradley A Warady; Susan L Furth
Journal:  J Am Soc Nephrol       Date:  2009-01-21       Impact factor: 10.121

9.  Multicenter Laboratory Comparison of Iohexol Measurement.

Authors:  George J Schwartz; Hongyue Wang; Brian Erway; Gunnar Nordin; Jesse Seegmiller; John C Lieske; Sten-Erik Back; W Greg Miller; John H Eckfeldt
Journal:  J Appl Lab Med       Date:  2018-03

10.  Significant differences when using creatinine, modification of diet in renal disease, or cystatin C for estimating glomerular filtration rate in ICU patients.

Authors:  Miklós Lipcsey; Mia Furebring; Sten Rubertsson; Anders Larsson
Journal:  Ups J Med Sci       Date:  2010-11-11       Impact factor: 2.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.